Collplant biotechnologies announces date for 2024 second quarter financial statements and conference call information

Conference call to be held on tuesday, august 20, 2024, at 10:00 a.m. u.s. edt rehovot, israel , aug. 6, 2024 /prnewswire/ -- collplant biotechnologies (nasdaq: clgn), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced that it will report financial statements for the second quarter of 2024 on tuesday, august 20, 2024, before the opening of the u.s. financial markets.
CLGN Ratings Summary
CLGN Quant Ranking